Halozyme Therapeutics | HALO - Aktywa

Cena Akcji
63.83
Dzienna Zmiana
0.77 1.22%
Miesięcznie
-1.24%
Rocznie
6.33%
Q2 Prognozy TE
63.96




Aktywa Zmiana Data
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Agios Pharmaceuticals USD 1.18B 112.24M 2026-03
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
Amarin USD 645.76M 25.01M 2026-03
Amgen USD 90.59B 445M 2025-12
Baxter International USD 19.85B 209M 2026-03
Cara Therapeutics USD 39.02M 4.73M 2025-09
Cytokinetics USD 1.42B 12.02M 2025-12
DBV Technologies USD 233.72M 123.22M 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Esperion Therapeutics USD 465.89M 101.87M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
MannKind USD 792.18M 297.54M 2025-12
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
United Therapeutics USD 7.88B 528.9M 2025-12
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12